Filing Details
- Accession Number:
- 0001127602-15-024242
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-05 15:53:45
- Reporting Period:
- 2015-08-03
- Filing Date:
- 2015-08-05
- Accepted Time:
- 2015-08-05 15:53:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1275654 | P David King | 531 South Spring Street Burlington NC 27215 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-03 | 50,000 | $80.37 | 131,153 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-03 | 33,700 | $127.68 | 97,453 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-03 | 16,300 | $128.43 | 81,153 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2015-08-03 | 50,000 | $0.00 | 50,000 | $80.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-02-20 | 2017-02-20 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 24,383 | Indirect | By grantor retained annuity trust |
| Common Stock | 19,046 | Indirect | By grantor retained annuity trust |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- Amount includes annuity payments made in shares of common stock from each of the reporting person's grantor retained annuity trusts to the reporting person in the amounts and on the dates indicated in notes 5 and 6 below.
- The price of $127.6816 per share represents a weighted average of sales prices ranging from $127.17 to $128.16 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $128.4339 per share represents a weighted average of sales prices ranging from $128.17 to $128.84 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Amount reflects an annuity payment of 6,840 shares made by the trust to the reporting person on July 10, 2015.
- Amount reflects an annuity payment of 8,250 shares made by the trust to the reporting person on July 21, 2015.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan.
- The option vested in three equal annual installments beginning on 2/20/2008 and is now fully exercisable.
Billionaire Hedge Funds
